Everyone Is Getting GLP-1 Microdosing WRONG (with Dr. Tyna Moore)
Dr. Tyna Moore — Everyone Is Getting GLP-1 Microdosing WRONG (with Dr. Tyna Moore)
Channel: The Doctor Youn Show and Doctor Youn · Our label: Naturopathic clinician educator · Source: youtube.com/watch?v=o3lyjWrsy9o
What this video covers
[music] I’m really excited to bring you today’s podcast. It is a followup to probably my most popular podcast interview I’ve ever done. A couple years ago, we did a podcast where she introduced her new technique of micro doing GLP-1 medications like Ompic. So she talked about it, gave us the information about what it does for her patients.
Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-07). Claims below are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.
Key points, in the speaker’s own framing
- We did have studies showing that those with type 2 diabetes and fatty liver who, you know, obviously were very metabolically un unsound were dealing with GLP-1 deficiency, but it’s not easy to test.
- Not to say that tursepides GIP isn’t helping but the studies are on a lot of the studies are on GLP-1 at least the earlier studies that I was looking at and semiglutide is 100% GLP-1.
- So, if we’re really looking at the anti-inflammatory benefits of GLP-1, we got to take GLP-1.
- Um I recently did a podcast um with a doctor where we did talk a lot about peptides, but would love to ask you your opinion on what’s going on with the state of peptides today.
- Now, there was recent legislation showing that the FDA may be approving a number of different peptides uh for legal use.
- And so we’re never the problem right now with what’s happening with the FDA and this approval process is they’re looking at specific peptides for specific conditions.
Read next
Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.